The Pollack Group Named AoR for Tower Cancer Research Foundation

Published on 19th January 2026

Worldcom partner The Pollack Group (TPG) has been appointed Agency of Record (AOR) for Tower Cancer Research Foundation, a nationally respected nonprofit advancing cancer research, supporting patients and families, and educating communities across the United States.

Founded in 1996, TCRF has funded pivotal studies and clinical trials while expanding education for healthcare professionals and the public. TPG was selected for its ability to unify scientific and human stories under a clear narrative, earn credible national visibility, and build long-term trust through earned media and thought leadership—capabilities that matter even more as AI-driven discovery rewards authoritative, verifiable content.

As AOR, The Pollack Group will lead:

  • Brand and message development aligned to Tower’s mission and impact
  • Earned media, PR, and thought leadership tied to clinical trials, research breakthroughs, partnerships, and key events
  • Digital and social strategy (organic and paid), GEO/SEO and lead generation, donor communications, and website development—all designed to create a durable, trusted content footprint

“Many of us have been affected by cancer in one way or another, which makes this partnership deeply personal,” said Stefan Pollack, president of The Pollack Group. “Tower Cancer Research Foundation has had a meaningful impact on millions of lives, yet much of its extraordinary work remains underrecognized. In today’s environment, visibility alone isn’t enough; organizations must earn trust through consistent, credible storytelling. Our role is to ensure Tower’s leadership, research, and human impact are visible, trusted, and understood, so the right audiences know where progress, hope, and innovation are happening.”

The integrated program will focus on credibility, consistency, and measurable engagement—so Tower’s work is not only seen, but believed, valued, and supported.

Related Insights

15 Jul 2026

The Ball Algorithm: How Screens Create the Market’s New Idols

The real paradigm shift in sports lies in how people discovered they…

Read more

11 Jul 2026

The Conversation Pharma Isn't Controlling — and What to Do About It

There is a fundamental mismatch between what pharmaceutical companies say and what…

Read more

10 Jul 2026

Built to Trust or Built to Fail? The Real State of Pharma Corporate Websites

A pharmaceutical company’s corporate website is more than a digital presence. It…

Read more